Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Jump Trading has quietly become one of the earliest proprietary trading firms to become active on prediction markets like Kalshi Inc., expanding into one of the hottest new derivatives markets, ...

Getting into the Association of South-East Asian Nations (ASEAN) is as hard as getting into heaven, says José Ramos-Horta (pictured), the president of Timor-Leste. After years in purgatory, the tiny ...

Former Harvard Chemistry professor Charles M. Lieber, who was convicted of lying to federal authorities about his ties to China in 2021, took a new job as a professor at a Chinese university last week ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...

Former Chief Scientific Officer and EVP of Business Development at Celgene to bring biopharma experience to digital biology company with multiple clinical-stage assets SALT LAKE CITY--(BUSINESS WIRE)- ...